Loading...
Market
Neuralink conducts more human trials by May 2025?
5
Resolution / Starting Odds
Yes • 50%
No • 50%
Announcements from Neuralink or regulatory filings for new clinical trials.
Story
Neuralink's First Human Implant Hits 100-Day Milestone, Faces Issues
May 9, 2024, 01:41 AM
Neuralink, the brain implant company founded by Elon Musk, has reached a significant milestone with its first human patient, 29-year-old Noland Arbaugh from Arizona, 100 days after the implantation of a brain chip. This device has enabled Arbaugh, who became quadriplegic due to a freak accident in 2016, to control a computer cursor and play video games using his mind. Despite this progress, the implant has encountered mechanical issues that reduced its data capturing capabilities. Arbaugh has expressed overwhelming satisfaction with the implant, noting improvements in his ability to perform tasks that were previously impossible for him.
View original story
Similar markets
Redesign and continue trials • 33%
Halt all human trials • 33%
Continue without changes • 34%
Broad support for continuation • 33%
Mixed reactions • 34%
Broad criticism leading to halt • 33%
Settled out of court • 33%
In favor of the employee • 33%
In favor of Neuralink • 34%